カテゴリー： QYResearch, 世界, 医療/バイオ

医療用ヒアルロン酸粘液補充のグローバル市場2023年：単回注射、複数回注射

◆英語タイトル：Global Medical Hyaluronic Acid Viscosupplementation Market Research Report 2023
	◆商品コード：QYR23MA8105 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2023年3月 ◆ページ数：95 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の医療用ヒアルロン酸粘液補充市場について調査・分析し、世界の医療用ヒアルロン酸粘液補充市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（単回注射、複数回注射）、用途別セグメント分析（変形性膝関節症、変形性股関節症、変形性股関節症、変形性肩関節症、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Anika Therapeutics、、Genzyme (Sanofi)、Bioventus、Seikagaku Corporation、LG Chem、Zimmer Biomet、Swiss Biomed Orthopaedics、TRB Chemedica、KalVista Pharma、Macopharmaなどが含まれています。世界の医療用ヒアルロン酸粘液補充市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医療用ヒアルロン酸粘液補充市場規模を推定する際に考慮しました。

・医療用ヒアルロン酸粘液補充市場の概要
- 製品の定義
- 医療用ヒアルロン酸粘液補充のタイプ別セグメント
- 世界の医療用ヒアルロン酸粘液補充市場規模：タイプ別分析（単回注射、複数回注射）
- 医療用ヒアルロン酸粘液補充の用途別セグメント
- 世界の医療用ヒアルロン酸粘液補充市場規模：用途別分析（変形性膝関節症、変形性股関節症、変形性股関節症、変形性肩関節症、その他）
- 世界の医療用ヒアルロン酸粘液補充市場規模予測（2018年-2029年）
- 医療用ヒアルロン酸粘液補充の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 医療用ヒアルロン酸粘液補充市場の競争状況およびトレンド

・医療用ヒアルロン酸粘液補充の地域別市場規模
- 北米の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- アメリカの医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- ヨーロッパの医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- アジア太平洋の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- 中国の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- 日本の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- 韓国の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- インドの医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- オーストラリアの医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- 中南米の医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）
- 中東・アフリカの医療用ヒアルロン酸粘液補充市場規模（2018年-2029年）

・タイプ別セグメント：単回注射、複数回注射
- 世界の医療用ヒアルロン酸粘液補充のタイプ別販売量（2018年-2023年）
- 世界の医療用ヒアルロン酸粘液補充のタイプ別売上（2018年-2023年）
- 世界の医療用ヒアルロン酸粘液補充のタイプ別価格

・用途別セグメント：変形性膝関節症、変形性股関節症、変形性股関節症、変形性肩関節症、その他
- 世界の医療用ヒアルロン酸粘液補充の用途別販売量（2018年-2023年）
- 世界の医療用ヒアルロン酸粘液補充の用途別売上（2018年-2023年）
- 世界の医療用ヒアルロン酸粘液補充の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Anika Therapeutics、、Genzyme (Sanofi)、Bioventus、Seikagaku Corporation、LG Chem、Zimmer Biomet、Swiss Biomed Orthopaedics、TRB Chemedica、KalVista Pharma、Macopharma

・産業チェーンと販売チャネルの分析
- 医療用ヒアルロン酸粘液補充産業チェーン分析
- 医療用ヒアルロン酸粘液補充の主要原材料
- 医療用ヒアルロン酸粘液補充の販売チャネル
- 医療用ヒアルロン酸粘液補充のディストリビューター
- 医療用ヒアルロン酸粘液補充の主要顧客

・医療用ヒアルロン酸粘液補充市場ダイナミクス
- 医療用ヒアルロン酸粘液補充の業界動向
- 医療用ヒアルロン酸粘液補充市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Medical Hyaluronic Acid Viscosupplementation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medical Hyaluronic Acid Viscosupplementation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical Hyaluronic Acid Viscosupplementation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medical Hyaluronic Acid Viscosupplementation include Anika Therapeutics
, Genzyme (Sanofi), Bioventus, Seikagaku Corporation, LG Chem, Zimmer Biomet, Swiss Biomed Orthopaedics, TRB Chemedica and KalVista Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Hyaluronic Acid Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Hyaluronic Acid Viscosupplementation.
The Medical Hyaluronic Acid Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Hyaluronic Acid Viscosupplementation market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Hyaluronic Acid Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Anika Therapeutics

Genzyme (Sanofi)
Bioventus
Seikagaku Corporation
LG Chem
Zimmer Biomet
Swiss Biomed Orthopaedics
TRB Chemedica
KalVista Pharma
Macopharma
Segment by Type
Single Injections
Multiple Injections
Segment by Application
Knee Osteoarthritis
Hip Osteoarthritis
Ankle Osteoarthritis
Shoulder Osteoarthritis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Hyaluronic Acid Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Hyaluronic Acid Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Medical Hyaluronic Acid Viscosupplementation Market Overview
1.1 Product Overview and Scope of Medical Hyaluronic Acid Viscosupplementation
1.2 Medical Hyaluronic Acid Viscosupplementation Segment by Type
1.2.1 Global Medical Hyaluronic Acid Viscosupplementation Market Value Comparison by Type (2023-2029)
1.2.2 Single Injections
1.2.3 Multiple Injections
1.3 Medical Hyaluronic Acid Viscosupplementation Segment by Application
1.3.1 Global Medical Hyaluronic Acid Viscosupplementation Market Value by Application: (2023-2029)
1.3.2 Knee Osteoarthritis
1.3.3 Hip Osteoarthritis
1.3.4 Ankle Osteoarthritis
1.3.5 Shoulder Osteoarthritis
1.3.6 Others
1.4 Global Medical Hyaluronic Acid Viscosupplementation Market Size Estimates and Forecasts
1.4.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue 2018-2029
1.4.2 Global Medical Hyaluronic Acid Viscosupplementation Sales 2018-2029
1.4.3 Global Medical Hyaluronic Acid Viscosupplementation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Hyaluronic Acid Viscosupplementation Market Competition by Manufacturers
2.1 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Hyaluronic Acid Viscosupplementation Average Price by Manufacturers (2018-2023)
2.4 Global Medical Hyaluronic Acid Viscosupplementation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Hyaluronic Acid Viscosupplementation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Hyaluronic Acid Viscosupplementation, Product Type & Application
2.7 Medical Hyaluronic Acid Viscosupplementation Market Competitive Situation and Trends
2.7.1 Medical Hyaluronic Acid Viscosupplementation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Hyaluronic Acid Viscosupplementation Players Market Share by Revenue
2.7.3 Global Medical Hyaluronic Acid Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Hyaluronic Acid Viscosupplementation Retrospective Market Scenario by Region
3.1 Global Medical Hyaluronic Acid Viscosupplementation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Hyaluronic Acid Viscosupplementation Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2018-2029
3.2.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2018-2023
3.2.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2024-2029
3.3 Global Medical Hyaluronic Acid Viscosupplementation Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2018-2029
3.3.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2018-2023
3.3.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2024-2029
3.4 North America Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.4.1 North America Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.4.3 North America Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.5.1 Europe Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.5.3 Europe Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.7.1 Latin America Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.7.3 Latin America Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2018-2029)
4.1.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2018-2023)
4.1.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2024-2029)
4.1.3 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2018-2029)
4.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2018-2029)
4.2.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2018-2023)
4.2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2024-2029)
4.2.3 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2018-2029)
4.3 Global Medical Hyaluronic Acid Viscosupplementation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2018-2029)
5.1.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2018-2023)
5.1.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2024-2029)
5.1.3 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2018-2029)
5.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2018-2029)
5.2.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2018-2023)
5.2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2024-2029)
5.2.3 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2018-2029)
5.3 Global Medical Hyaluronic Acid Viscosupplementation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Anika Therapeutics

6.1.1 Anika Therapeutics
Corporation Information
6.1.2 Anika Therapeutics
Description and Business Overview
6.1.3 Anika Therapeutics
Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Anika Therapeutics
Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.1.5 Anika Therapeutics
Recent Developments/Updates
6.2 Genzyme (Sanofi)
6.2.1 Genzyme (Sanofi) Corporation Information
6.2.2 Genzyme (Sanofi) Description and Business Overview
6.2.3 Genzyme (Sanofi) Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Genzyme (Sanofi) Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.2.5 Genzyme (Sanofi) Recent Developments/Updates
6.3 Bioventus
6.3.1 Bioventus Corporation Information
6.3.2 Bioventus Description and Business Overview
6.3.3 Bioventus Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bioventus Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.3.5 Bioventus Recent Developments/Updates
6.4 Seikagaku Corporation
6.4.1 Seikagaku Corporation Corporation Information
6.4.2 Seikagaku Corporation Description and Business Overview
6.4.3 Seikagaku Corporation Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Seikagaku Corporation Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.4.5 Seikagaku Corporation Recent Developments/Updates
6.5 LG Chem
6.5.1 LG Chem Corporation Information
6.5.2 LG Chem Description and Business Overview
6.5.3 LG Chem Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LG Chem Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.5.5 LG Chem Recent Developments/Updates
6.6 Zimmer Biomet
6.6.1 Zimmer Biomet Corporation Information
6.6.2 Zimmer Biomet Description and Business Overview
6.6.3 Zimmer Biomet Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zimmer Biomet Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.6.5 Zimmer Biomet Recent Developments/Updates
6.7 Swiss Biomed Orthopaedics
6.6.1 Swiss Biomed Orthopaedics Corporation Information
6.6.2 Swiss Biomed Orthopaedics Description and Business Overview
6.6.3 Swiss Biomed Orthopaedics Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Swiss Biomed Orthopaedics Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.7.5 Swiss Biomed Orthopaedics Recent Developments/Updates
6.8 TRB Chemedica
6.8.1 TRB Chemedica Corporation Information
6.8.2 TRB Chemedica Description and Business Overview
6.8.3 TRB Chemedica Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 TRB Chemedica Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.8.5 TRB Chemedica Recent Developments/Updates
6.9 KalVista Pharma
6.9.1 KalVista Pharma Corporation Information
6.9.2 KalVista Pharma Description and Business Overview
6.9.3 KalVista Pharma Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 KalVista Pharma Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.9.5 KalVista Pharma Recent Developments/Updates
6.10 Macopharma
6.10.1 Macopharma Corporation Information
6.10.2 Macopharma Description and Business Overview
6.10.3 Macopharma Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Macopharma Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.10.5 Macopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Hyaluronic Acid Viscosupplementation Industry Chain Analysis
7.2 Medical Hyaluronic Acid Viscosupplementation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Hyaluronic Acid Viscosupplementation Production Mode & Process
7.4 Medical Hyaluronic Acid Viscosupplementation Sales and Marketing
7.4.1 Medical Hyaluronic Acid Viscosupplementation Sales Channels
7.4.2 Medical Hyaluronic Acid Viscosupplementation Distributors
7.5 Medical Hyaluronic Acid Viscosupplementation Customers
8 Medical Hyaluronic Acid Viscosupplementation Market Dynamics
8.1 Medical Hyaluronic Acid Viscosupplementation Industry Trends
8.2 Medical Hyaluronic Acid Viscosupplementation Market Drivers
8.3 Medical Hyaluronic Acid Viscosupplementation Market Challenges
8.4 Medical Hyaluronic Acid Viscosupplementation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用ヒアルロン酸粘液補充のグローバル市場2023年：単回注射、複数回注射(Global Medical Hyaluronic Acid Viscosupplementation Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医療用ヒアルロン酸粘液補充のグローバル市場2023年：単回注射、複数回注射

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp